Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-07-16

Clinical Trial Results: Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating quality of life improvements in prostate cancer survivors with androgen deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2026-07-16